BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Pipeline Drugs 

Biotechnology Encyclopedia

Radiation Therapy

Radiation therapy (or radiotherapy) is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis). Although radiotherapy is often used as part of curative therapy, it is occasionally used as a palliative treatment, where cure is not possible and the aim is for symptomatic relief. Other rare uses are to wipe out the immune system prior to transplant to reduce the incidence of tissue rejection, called TBI or Total Body Irradiation; to calm hyperactive muscles -- such as might cause twitchy eyes -- with mild superficial treatments; and to form scar tissue around a stent to reinforce the vascular wall.

Application

Radiotherapy is commonly used for the treatment of tumours. It may be used as the primary therapy. It is also common to combine radiotherapy with surgery and/or chemotherapy and/or hormone therapy. The most common tumours treated with radiotherapy are breast cancer, prostate cancer, lung cancer, colorectal cancer, head & neck cancers, gynaecological tumours, bladder cancer and lymphoma, although the cancer's stage (progress) and invasion into lymph nodes, as well as and other health and (unfortunately) monetary factors affect which treatment will have the greatest possibility of success.

Radiation therapy is commonly applied just to the localised area involved with the tumour. Often the radiation fields also include the draining lymph nodes. It is possible but uncommon to give radiotherapy to the whole body, or entire skin surface.

Side effects

Although the actual treatment is painless, using external radiation (see below) to tackle tumours inevitably leads to side effects. The side effects can occur during treatment (acute side effects such as soreness and redness over the affected area; nausea and vomiting) or long after treatment has finished (late side effects reflecting permanent organ damage). Implanting radioactive sources has the usual side effects associated with invasive procedures.

Dosage

Radiation Therapy can, to some extent, be regarded as a drug like any other. It is therefore useful to distinguish the total dose from the fractionation schedule. Radiation therapy is usually given daily, the dose depends primarily on tumor type, but many other factors such as whether radiation is given alone or with chemotherapy, before or after surgery, the success of surgery and its findings and many other reasons that are considered by the treating doctor (known as a radiation oncologist). The typical dose for a solid epithelial tumor may range from 50 to 70 Gray or more, while lymphomas (white cell) tumors might receive doses closer to 20 to 40 Gray given in daily doses (a daily dose is a fraction);In adults these are typically ~2 Gy (Gray (unit)) per fraction. These small frequent doses allow healthy cells time to grow back, repairing damage inflicted by the radiation. In short, total dose can be given in daily fractions using external beam radiation or the total dose can be given via other methods such as implants that deliver radiation continuously over a given timeframe. Depending on the implant type, it may be given as a fraction (e.g. High Dose Rate HDR) over minutes or hours or as another example permanent seeds may be implanted (such as in the prostate) which slowly deliver radiation until the seeds become inactive.

Fractionation Schedules

As mentioned above, the typical fractionation schedule is 2Gy/fraction, with 1 fraction/day for an adult patient. However, there are alternative fractionation schedules that have been tried. One of the best-known was the CHART (Continous Hyperfractionated Accelerated RadioTherapy) regime for lung cancer, which used 2 or 3 smaller fractions per day in the treatment of lung cancer. Although reasonably successful, this imposed huge strains on the departments delivering the service, as it required multiple treatments everyday, including weekends. In some paediatric cancers, fractionation schedules tend to give 1.5 - 1.7Gy/fraction. The reason for this is that fractionation effects the balance between acute and late toxicity, and the smaller the fraction, the smaller the late effects. Obviously late effects are of more concern in paediatric patients than adults.

How it works

Radiation therapy works by damaging the DNA of cells. The damage is caused by an electromagnetic, electron or proton beam directly or indirectly ionizing the atoms which make up DNA chain. Indirect ionization happens as a result of the ionization of oxygen, forming free radicals, which then damage the DNA. In the most common forms of radiation therapy, most of the radiation effect is through free radicals. Because cells have mechanisms for repairing DNA breakage, where the DNA is broken on both strands of the DNA are the most significant in modifying cell charactaristics. Because cancer cells generally are undifferentiated and stem cell-like, they reproduce more, and have an dimished ability to repair sublethal damage compared to most healthy differentiated cells. The DNA damage is inherited through cell division, accumulating damage to the cancer cells, causing them to die or reproduce more slowly. Proton radiotherapy works by sending protons with varying kinetic energy to precisely stop at the tumor. Being researched is antiproton radiotherapy which would require fewer treatments than proton radiotherapy.

Implications

Tumours don't repair the radiation damage as well as nonmalignant tissue.

Most cells, however, die only during a specific phase of cellular reproduction, which has many curious implications:

  • Some slowly growing tumours (for example, prostate) may be treated best by not treating them at all, since the patient will likely die from other causes, such as old age, before the cancer kills.
  • It is thought that tumours which outgrow their blood supply, causing a low-oxygen state known as hypoxia, are more resistant to the effects of radiation because they reproduce less frequently, and are not subject to indirect damage caused by free radicals produced by the ionisation of oxygen.
  • Some brain tumours do not die at extremely high doses. It is an open subject as to the mechanism by which they survive, but perhaps they do not reproduce in the usual way.

Kinds of radiation therapy

Three main divisions of radiotherapy are external beam radiotherapy (XBRT) or teletherapy, brachytherapy or sealed source radiotherapy and unsealed source radiotherapy. The differences relate to the position of the radiation source; external is outside the body, while sealed and unsealed source radiotherapy has radioactive material delivered internally. Brachytherapy sealed sources are usually extracted later, while unsealed sources are injected into the body. Proton therapy is a special case of external beam radiotherapy where the particles are protons.

Roughly half of the 2500 worldwide radiotherapy clinics are in the US (as of 2001).

3-dimensional radiation therapy

A procedure that uses a computer to create a 3-dimensional picture of the tumor. The patient first undergoes a CT scan in the treatment position, a process known as simulation. The images from the scan are transferred to a treatment planning computer, and the physician traces the outline of the tumor and normal organs on each slice of the CT scan. The treatment planning computer allows the physician to try different beam arrangements on the patient, a process known as virtual simulation. The treatment planning computer may show the beam's eye view (BEV), which is a visual depiction of the tumor in relation to the bony anatomy of the patient and normal organs. Using information from the BEV, physicians can design custom blocking of parts of the radiation beam in order to spare normal tissue as much as posible, which allows doctors to give the highest possible dose of radiation to the tumor.

Also called 3-dimensional conformal radiation therapy.

 
Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
 Biotech100 list of companies
Pipeline drugs for the Biotech100


Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index


Sponsored Links


Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?

Key Biotech Terms


Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 
All text is available under the terms of the GNU Free Documentation License (see Copyrights for details). Disclaimers. Wikipedia is powered by MediaWiki, an open source wiki engine..
 


Copyright 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com